Johnson & Johnson

Covidien (NYSE: COV), which currently is being courted by medical device maker Medtronic (NYSE: MDT), is scheduled to report its fiscal third-quarter results Friday, July 25, before the markets open. Like AbbVie's deal to acquire Shire and other similar deals, Medtronic is looking to...

U.S. stocks rose as investors and traders find comfort in corporate earnings that continue to come in at better-than-expected levels. Although it's still very early in to earning season, Intel Corp. (NASDAQ: INTC) reported better-than-expected results and stronger-than-expected PC sales,...

U.S. stocks were mixed with the NASDAQ index declining after the Fed's Chief Janet Yellen suggested that some sectors are characterized by "stretched" valuations. In prepared remarks to the Senate Banking Committee, Yellen also claimed that interest rates could rise sooner and at...

U.S. stocks rose as earning season unofficially kicked off with Citigroup reporting better than expected earnings. The Dow Jones Industrial average set new intra-day records, hitting an all time high of 17,088.43 as investors appear to be comfortable with holding blue chips instead of...

After Alcoa (NYSE: AA) and Wells Fargo (NYSE: WFC) kicked off the second-quarter earnings season last week, things ramp up this week with reports from many of the big banks, some tech giants and other blue-chips. Citigroup (NYSE: C), Goldman Sachs (NYSE: GS) and J.P. Morgan (NYSE: JPM) get...

U.S. stocks were little changed despite an ADP jobs report showing better-than-expected numbers. The ADP report comes ahead of the non-farm payrolls due on Thursday. Analysts are expecting the payrolls to confirm 212,000 jobs were added in June. The markets will close at 1:00 p.m. on Thursday...

U.S. stocks were little changed as the second quarter comes to an end. Investors and traders are likely spending the last day of the quarter the same way they did to ring in the quarter: questioning the direction of the U.S. economy and wondering what is in store in the coming quarter. One...

Sunni insurgents tightened their grip on northern Iraq over the weekend when they overtook Tal Afar, stirring worries that the nation may fall into a civil war. Rebels from the Islamic State of Iraq seized the mostly ethnic Turkmen city on Sunday as they pressed closer to the capital. The...

U.S. stocks rose as investors found that the positives in the U.S. services sector outweighed concerns over an escalating conflict in Ukraine. The Institute for Supply Management said that its service-sector index rose to 55.2. Any reading above 50.0 indicates an expansion. Also, the index...

U.S. stocks held on to strong gains as U.S. industrial production rose more than projected. The Fed confirmed it will maintain a "friendly" policy that will support the economic recovery. According to Fed Chief Janet Yellen there are three main concerns the central bank is facing. Specifically...

U.S. stock futures were pointing towards a modestly higher open as investors found enough optimism from Dow components Coca-Cola and Johnson & Johnson who both reported better than expected quarterly results. Investors were further spooked by reports of pro-Russian separatists taking...

The new earnings season kicks into high gear this shortened week. Highlights will include quarterly reports from Bank of America, Citigroup and Goldman Sachs, from Intel and IBM, and from Coca-Cola, which are all expected to post earnings declines, as well as from Google and Johnson & Johnson...

In a period when many biotech stocks were slipping, short sellers moved on many of the leading biotech and emerging pharmaceuticals between the March 14 and March 31 settlement dates. But Amgen (NASDAQ: AMGN), Celgene (NASDAQ: CELG) and Dendreon (NASDAQ: DNDN) were among those that bucked the...

Most traders tend to seek out stocks that are exhibiting positive momentum trends in order to capitalize on price strength over short periods of time. There are a number of different screens and analysis profiles that you can implement to find these stocks, but an innovative ETF was introduced...

After largely shying away in the previous period, short sellers found renewed interest in many of the leading biotech and emerging pharmaceutical companies between the February 28 and March 14 settlement dates. But Celgene (NASDAQ: CELG), Medivation (NASDAQ: MDVN) and Pharmacyclics (NASDAQ: PCYC...